Home » Topics » BioWorld Science

BioWorld Science
RSS

Vyriad opens phase II trial of Voyager-V1 in combination with cemiplimab for cancer

May 14, 2020

Merck & Co. reports phase II data on MK-6482 for VHL disease-associated ccRCC

May 14, 2020

SHISA4 expression proven useful to monitor nintedanib therapy in patients with IPF

May 14, 2020

Immunic receives approval to begin phase II study of IMU-838 for COVID-19

May 14, 2020

Blueprint Medicines' BLU-847 shows activity against wild-type and mutant tyrosine kinase receptors

May 14, 2020

Improved therapeutic index could reduce opioid toxicity

May 14, 2020

miRNA-126-5p circulating levels are decreased in severe sepsis

May 14, 2020

New adenosine A2A and A2B receptors disclosed by Merck KGaA

May 14, 2020

ViiV Healthcare discovers new HIV-1 Capsid protein p24 assembly inhibitors

May 14, 2020

Nurix Therapeutics patents Bruton tyrosine kinase-degrading compounds

May 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...